tiprankstipranks
HeraMED Ltd. (DE:1I4)
FRANKFURT:1I4

HeraMED Ltd. (1I4) Stock Price & Analysis

0 Followers

1I4 Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€0.01 - €0.05
Previous Close€0.02
Volume0.00
Average Volume (3M)N/A
Market Cap
€11.80M
Enterprise Value€11.67M
Total Cash (Recent Filing)$3.56M
Total Debt (Recent Filing)$3.42M
Price to Earnings (P/E)
Beta0.39
Aug 27, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding353,249,818
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

1.64%0.00%0.00%98.36%
1.64%
Insiders
0.00% Other Institutional Investors
98.36% Public Companies and
Individual Investors

1I4 FAQ

What was HeraMED Ltd.’s price range in the past 12 months?
HeraMED Ltd. lowest stock price was €0.01 and its highest was €0.05 in the past 12 months.
    What is HeraMED Ltd.’s market cap?
    Currently, no data Available
    When is HeraMED Ltd.’s upcoming earnings report date?
    HeraMED Ltd.’s upcoming earnings report date is Aug 27, 2024 which is in 54 days.
      How were HeraMED Ltd.’s earnings last quarter?
      HeraMED Ltd. released its earnings results on Mar 28, 2024. The company reported -€0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.007.
        Is HeraMED Ltd. overvalued?
        According to Wall Street analysts HeraMED Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does HeraMED Ltd. pay dividends?
          HeraMED Ltd. does not currently pay dividends.
          What is HeraMED Ltd.’s EPS estimate?
          HeraMED Ltd.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does HeraMED Ltd. have?
          HeraMED Ltd. has 633,249,800 shares outstanding.
            What happened to HeraMED Ltd.’s price movement after its last earnings report?
            HeraMED Ltd. reported an EPS of -€0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of HeraMED Ltd.?
              Currently, no hedge funds are holding shares in DE:1I4
              ---

              HeraMED Ltd. Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              20 days / 200 days
              Momentum
              -52.77%
              12-Months-Change

              Fundamentals

              Return on Equity
              -268.38%
              Trailing 12-Months
              Asset Growth
              -53.18%
              Trailing 12-Months

              Company Description

              HeraMED Ltd.

              HeraMED Ltd is engaged in developing innovative, connected pregnancy monitoring solutions for home and professional use. It has developed a foetal heart beat monitor called HeraBEAT which is a medical-grade, clinically-validated, smart and connected Ultrasound Foetal Doppler device predominantly for use by an expectant mother to self-monitor her foetus' heart rate (FHR).
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              ALUMIL S.A.
              FinLab AG
              Nano-X Imaging
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis